# HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).

> **NCT04472845** · NA · RECRUITING · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 1018 (estimated)

## Conditions studied

- Breast Cancer
- Hypofractionation
- Radiotherapy Side Effect

## Interventions

- **RADIATION:** 1 week RT
- **RADIATION:** 2 week RT

## Key facts

- **NCT ID:** NCT04472845
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-30
- **Primary completion:** 2023-08-20
- **Final completion:** 2028-08-20
- **Target enrollment:** 1018 (ESTIMATED)
- **Last updated:** 2022-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04472845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04472845, "HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04472845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*